For more than 30 years, Thoratec has been committed to developing advanced medical technologies to improve patient survival and quality of life. Thoratec provides the broadest mechanical circulatory support portfolio to treat the full range of clinical needs. From acute to chronic heart failure, Thoratec offers proven device-based therapies to provide a new beginning for patients and their families. Additionally, the company's wholly-owned subsidiary, International Technidyne Corporation (ITC), manufactures and sells a wide range of equipment for hemostasis management and point-of-care testing.
Thoratec employs more than 1,000 people worldwide. We are based in Pleasanton, California, with facilities in Burlington, Massachusetts; Rancho Cordova, California; Edison, New Jersey; and Cambridgeshire, UK.
With nearly 15,000 patient implants, Thoratec® Corporation is a world leader in products to treat cardiovascular disease. Including the recently FDA approved HeartMate II® for bridge to transplantation.